This site is intended for healthcare professionals only
LoginRegister
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and olderGSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of...
WBUHS Opens Online Registration Portal for MD, MS Courses for 2024-25 Session.CDSCO develops National Drugs Licensing System Portal for pharma manufacturers to adopt updated...
Ajanta Pharma Vice Chairman Madhusudan Agrawal honoured withAjanta Pharma Vice Chairman Madhusudan Agrawal honoured with 'Consular of the Year' award
Shut Non-Compliant Firms: Panel Demands Strict Action Against Counterfeit DrugsShut Non-Compliant Firms: Panel Demands Strict Action Against Counterfeit Drugs
Piramal Gets Delhi HC Relief, Decades-Old Spurious Tixylix Cough Syrup Case QuashedSetback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck gets rights to develop, commercialize Jiangsu Hengrui Pharma heart drug worldwide, excluding...
Pune Pharmacist Loses Rs 95 Lakh in Medical Store DealNovo Nordisk, The United Bio-Technology ink pact for 'triple G' obesity drug
USFDA approves Abbott Tendyne to replace mitral valve without open-heart surgeryAbbott begins new Intravascular Lithotripsy trial to improve outcomes in Coronary Artery Disease...
GSK application to expand use of Nucala for COPD accepted for review by EMAGSK application to expand use of Nucala for COPD accepted for review by EMA
Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopeniaSanofi Tolebrutinib under USFDA priority review for multiple sclerosis
Dr Mike Graham to become new Head of RnD for Bayer Crop Science divisionDr Mike Graham to become new Head of RnD for Bayer Crop Science division
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancerAstraZeneca, Harbour BioMed join hands to discover, develop next-generation therapeutic antibodies
X